As you will see - the format of the newsletter has been revised and we would very much appreciate your feedback as to whether you find this format reader friendly.
Please send me any information you would like included in the next issue and also any comments you have on the new format, by noon, Wednesday 21 October 2009.
Best regards, Erin
Ms Erin Sparrow Assistant New and Under-utilized Vaccines Implementation (NUVI) Expanded Programme on Immunization (EPI) Department of Immunization, Vaccines and Biologicals (IVB) World Health Organization | Avenue Appia 20 | 1211 Geneva | Switzerland Email: sparrowe@who.int | Tel: +41 22 791 12 38 | Fax: +41 22 791 41 93 Web: www.who.int/nuvi/en/
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum You cannot post attachments in this forum You can download attachments in this forum
TechNet21 is generously supported by the Bill and Melinda Gates Foundation, under the oversight of WHO and UNICEF. The information in this forum is provided by users, as a service. All contributions are reviewed prior to posting, and all postings are attributed to the authors. The details given in emails will not be voluntarily shared or sold to any outside company and will only be used for verification and to identify postings, if necessary. The authors are solely responsible for their submissions, and the readers are solely responsible for the interpretation of these submissions. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to this forum.
For posts where the author is a WHO staff member, the author alone is reponsible for the views expressed and they do not necessarily represent the decisions, guidelines, recommendations or policies of WHO.